Patents by Inventor Bernhard Scheuble

Bernhard Scheuble has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7445818
    Abstract: The invention relates to a matrix liquid crystal display containing integrated non-linear elements and a liquid crystal mixture which has a particularly high resistivity.
    Type: Grant
    Filed: December 18, 2006
    Date of Patent: November 4, 2008
    Assignee: Merck Patent Gesellschaft Mit Beschrankter Haftung
    Inventors: Georg Weber, Ludwig Pohl, Reinhard Hittich, Herbert Plach, Bernhard Scheuble, Takamasa Oyama, Bernhard Rieger, Hans Adolf Kurmeier, Ekkehard Bartmann
  • Publication number: 20070275182
    Abstract: The invention relates to a matrix liquid crystal display containing integrated non-linear elements and a liquid crystal mixture which has a particularly high resistivity.
    Type: Application
    Filed: December 18, 2006
    Publication date: November 29, 2007
    Inventors: Georg Weber, Ludwig Pohl, Reinhard Hittich, Herbert Plach, Bernhard Scheuble, Takamasa Oyama, Bernhard Rieger, Hans Kurmeier, Ekkehard Bartmann
  • Patent number: 7186447
    Abstract: Described are matrix liquid crystal displays having two plane parallel support plates which together with a frame form a cell, integrated non-linear elements for switching individual picture elements on the support plates and a nematic liquid crystal mixture which is present in the cell and has a positive dielectric anisotropy and high resistivity. The liquid crystal mixture has a nematic phase range of at least 60° C., a maximum viscosity at 20° C. of 30 mPa·s and a mean dielectricity constant ??8. The liquid crystal mixture contains: a) at least 10% by weight of a liquid-crystalline component B having one or more compounds of the following formulae: and b) up to 90% by weight of a liquid-crystalline component A having one or more compounds with a dielectric anisotropy of ?1.5 to 1.
    Type: Grant
    Filed: March 17, 2005
    Date of Patent: March 6, 2007
    Assignee: Merck Patent GmbH
    Inventors: Georg Weber, Ludwig Pohl, Reinhard Hittich, Herbert Plach, Bernhard Scheuble, Takamasa Oyama, Bernhard Rieger, Hans Adolf Kurmeier, Ekkehard Bartmann
  • Patent number: 7090986
    Abstract: A naturally occurring protein isolated from the saliva of the medicinal leech Hirudo medicinalis is described which strongly binds to collagen thus acting as an inhibitor of natural platelet adhesion to collagen. The protein has a molecular weight of about 12,000, an acidic isoelectric point and contains six cysteins. The protein was sequenced and the gene was cloned from a H. medicinalis cDNA-library. Procedures for producing such polypeptide by recombinant techniques are disclosed. The recombinant and the natural occurring proteins are potent inhibitors of collagen-dependent platelet adhesion and therefore useful for the therapeutic treatment of various conditions related to heart disease and diseases of the circulation system. Furthermore, the protein is useful for coating natural or artificial collagen surfaces in order to render them nonadhesive for cells and prevent the activation of cells.
    Type: Grant
    Filed: June 16, 2005
    Date of Patent: August 15, 2006
    Assignee: Merck Patent GmbH
    Inventors: Wolfgang Strittmatter, Detlef Güssow, Uwe Hofmann, Jürgen Hemberger, Zisi Fotev, Bernhard Scheuble
  • Publication number: 20060094079
    Abstract: A naturally occurring protein isolated from the saliva of the medicinal leech Hirudo medicinalis is described which strongly binds to collagen thus acting as an inhibitor of natural platelet adhesion to collagen. The protein has a molecular weight of about 12,000, an acidic isoelectric point and contains six cysteins. The protein was sequenced and the gene was cloned from a H. medicinalis cDNA-library. Procedures for producing such polypeptide by recombinant techniques are disclosed. The recombinant and the natural occurring proteins are potent inhibitors of collagen-dependent platelet adhesion and therefore useful for the therapeutic treatment of various conditions related to heart disease and diseases of the circulation system. Furthermore, the protein is useful for coating natural or artificial collagen surfaces in order to render them nonadhesive for cells and prevent the activation of cells.
    Type: Application
    Filed: June 16, 2005
    Publication date: May 4, 2006
    Inventors: Wolfgang Strittmatter, Detlef Gussow, Uwe Hofmann, Jurgen Hemberger, Zisi Fotev, Bernhard Scheuble
  • Patent number: 6962801
    Abstract: A naturally occurring protein isolated from the saliva of the medicinal leech Hirudo medicinalis is described which strongly binds to collagen thus acting as an inhibitor of natural platelet adhesion to collagen. The protein has a molecular weight of about 12,000, an acidic isoelectric point and contains six cysteins. The protein was sequenced and the gene was cloned from a H. medicinalis cDNA-library. Procedures for producing such polypeptide by recombinant techniques are disclosed. The recombinant and the natural occurring proteins are potent inhibitors of collagen-dependent platelet adhesion and therefore useful for the therapeutic treatment of various conditions related to hard disease and diseases of the circulation system. Furthermore the protein is useful for coating natural or artificial collagen surfaces in order to render them nonadhesive for cells and prevent the activation of cells.
    Type: Grant
    Filed: May 17, 2004
    Date of Patent: November 8, 2005
    Assignee: Merck Patent GmbH
    Inventors: Wolfgang Strittmatter, Detlef Güssow, Uwe Hofmann, Jürgen Hemberger, Zisi Fotev, Bernhard Scheuble
  • Publication number: 20050196551
    Abstract: The invention relates to a matrix liquid crystal display containing integrated non-linear elements and a liquid crystal mixture which has a particularly high resistivity.
    Type: Application
    Filed: March 17, 2005
    Publication date: September 8, 2005
    Inventors: Georg Weber, Ludwig Pohl, Reinhard Hittich, Herbert Plach, Bernhard Scheuble, Takamasa Oyama, Bernhard Rieger, Hans Kurmeier, Ekkehard Bartmann
  • Patent number: 6905740
    Abstract: The invention relates to a matrix liquid crystal display containing integrated non-linear elements and a liquid crystal mixture which has a particularly high resistivity.
    Type: Grant
    Filed: March 10, 2003
    Date of Patent: June 14, 2005
    Assignee: Merck Patent GmbH
    Inventors: Georg Weber, Ludwig Pohl, Reinhard Hittich, Herbert Plach, Bernhard Scheuble, Takamasa Oyama, Bernhard Rieger, Hans Adolf Kurmeier, Ekkehard Bartmann
  • Publication number: 20050065084
    Abstract: A naturally occurring protein isolated from the saliva of the medicinal leech Hirudo medicinalis is described which strongly binds to collagen thus acting as an inhibitor of natural platelet adhesion to collagen. The protein has a molecular weight of about 12 000, an acidic isoelectric point and contains six cysteins. The protein was sequenced and the gene was cloned from a H. medicinalis cDNA-library. Procedures for producing such polypeptide by recombinant techniques are disclosed. The recombinant and the natural occurring proteins are potent inhibitors of collagen-dependent platelet adhesion and therefore useful for the therapeutic treatment of various conditions related to hard disease and diseases of the circulation system. Furthermore the protein is useful for coating natural or artificial collagen surfaces in order to render them nonadhesive for cells and prevent the activation of cells.
    Type: Application
    Filed: May 17, 2004
    Publication date: March 24, 2005
    Inventors: Wolfgan Strittmatter, Detlef Gussow, Uwe Hofmann, Jurgen Hemberger, Zisi Fotev, Bernhard Scheuble
  • Patent number: 6774107
    Abstract: A naturally occurring protein isolated from the saliva of the medicinal leech Hirudo medicinalis is described which strongly binds to collagen thus acting as an inhibitor of natural platelet adhesion to collagen. The protein has a molecular weight of about 12,000, an acidic isoelectric point and contains six cysteins. The protein was sequenced and the gene was cloned from a H. medicinalis cDNA-library. Procedures for producing such polypeptide by recombinant techniques are disclosed. The recombinant and the natural occurring proteins are potent inhibitors of collagen-dependent platelet adhesion and therefore useful for the therapeutic treatment of various conditions related to heart disease and diseases of the circulation system. Furthermore, the protein is useful for coating natural or artificial collagen surfaces in order to render them nonadhesive for cells and prevent the activation of cells.
    Type: Grant
    Filed: September 17, 2001
    Date of Patent: August 10, 2004
    Assignee: Merck Patent GmbH
    Inventors: Wolfgang Strittmatter, Detlef Güssow, Uwe Hofmann, Jürgen Hemberger, Zisi Fotev, Bernhard Scheuble
  • Publication number: 20030207046
    Abstract: The invention relates to a matrix liquid crystal display containing integrated non-linear elements and a liquid crystal mixture which has a particularly high resistivity.
    Type: Application
    Filed: March 10, 2003
    Publication date: November 6, 2003
    Applicant: Merck Patent Gesellschaft mit beschrankter Haftung
    Inventors: Georg Weber, Ludwig Pohl, Reinhard Hittich, Herbert Plach, Bernhard Scheuble, Takamasa Oyama, Bernhard Rieger, Hans Adolf Kurmeier, Ekkehard Bartmann
  • Patent number: 6562419
    Abstract: The invention relates to a matrix liquid crystal display containing integrated non-linear elements and a liquid crystal mixture which has a particularly high resistivity.
    Type: Grant
    Filed: December 21, 1999
    Date of Patent: May 13, 2003
    Assignee: MERCK Patent Gesellschaft mit beschrankter Haftung
    Inventors: Georg Weber, Ludwig Pohl, Reinhard Hittich, Herbert Plach, Bernhard Scheuble, Takamasa Oyama, Bernhard Rieger, Hans Adolf Kurmeier, Ekkehard Bartmann
  • Publication number: 20020060761
    Abstract: The invention relates to an electrooptical system according to the preamble of claim 1, where the angle &psgr;, which the polarization device forms on the input side with the directors of the liquid-crystal molecules on the 1st substrate surface, is optimized in order to achieve high contrast and/or high brightness and/or high viewing angle independence and/or the color values.
    Type: Application
    Filed: July 23, 2001
    Publication date: May 23, 2002
    Applicant: Merck Patent GmbH
    Inventors: Bernhard Scheuble, Gunter Baur, Waltraud Fehrenbach, Barbara Staudacher
  • Patent number: 6327010
    Abstract: An electrooptical system contains: (a) a twisted nematic liquid-crystal layer, with an input side and an output side, which is positioned between a first substrate and a second substrate, each of whose inside surface is provided with an electrode coating and an alignment layer thereon, the director of said liquid crystal layer having a parallel edge alignment and a twist angle of 0°≦&bgr;≦1000, (b) at least one compensation layer for compensating the optical path difference of the liquid-crystal layer d·&Dgr;n, and (c) at least one device for linear polarization of light in such an arrangement that light, before entering and after exiting the liquid-crystal layer, passes through a polarization device, I.
    Type: Grant
    Filed: December 19, 1996
    Date of Patent: December 4, 2001
    Assignee: Merck Patent Gesellschaft mit beschrankter Haftung
    Inventors: Bernhard Scheuble, Günter Baur, Waltraud Fehrenbach, Barbara Staudacher
  • Patent number: 6210760
    Abstract: Supertwist liquid crystal displays having very short switching times are obtained if the nematic liquid crystal mixture contains at least one component chosen from group A consisting of compounds of the formulae AI to AVI: wherein R1 and R2 in each case independently of one another are each R and R is alkyl having 1-12 C atoms, wherein one or two non-adjacent CH2 groups can also be replaced by —O—, —CH═CH—, —CO—, —O—CO— or —CO—O—, and up to four other components.
    Type: Grant
    Filed: December 8, 1998
    Date of Patent: April 3, 2001
    Assignee: Merck Patent Gesellschaft mit beschrankter Haftung
    Inventors: Georg Weber, Herbert Plach, Takamasa Oyama, Hiroki Yoshitake, Bernhard Scheuble, Reinhard Hittich, Hans Adolf Kurmeier, Eike Poetsch, Klaus Peter Stahl
  • Patent number: 6004479
    Abstract: The invention relates to a matrix liquid crystal display containing integrated non-linear elements and a liquid crystal mixture which has a particularly high resistivity.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: December 21, 1999
    Assignee: Merck KGAA
    Inventors: Georg Weber, Ludwig Pohl, Reinhard Hittich, Herbert Plach, Bernhard Scheuble, Takamasa Oyama, Bernhard Rieger, Hans Adolf Kurmeier, Ekkehard Bartmann
  • Patent number: 5876626
    Abstract: Supertwist liquid crystal displays having very short switching times are obtained if the nematic liquid crystal mixture contains at least one component chosen from group A consisting of compounds of the formulae AI to AVI: ##STR1## wherein R.sup.1 and R.sup.2 in each case independently of one another are each R and R is alkyl having 1-12 C atoms, wherein one or two non-adjacent CH.sub.2 groups can also be replaced by --O--, --CH.dbd.CH--, --CO--, --O--CO-- or --CO--O--, and up to four other components.
    Type: Grant
    Filed: December 7, 1994
    Date of Patent: March 2, 1999
    Assignee: Merck patent Gesellschaft mit Beschrankter Haftung
    Inventors: Georg Weber, Herbert Plach, Takamasa Oyama, Hiroki Yoshitake, Bernhard Scheuble, Reinhard Hittich, Hans Adolf Kurmeier, Eike Poetsch, Klaus Peter Stahl
  • Patent number: 5641429
    Abstract: Fluorobenzene derivatives of formula I, ##STR1## in which R an alkenyl radical as further defined in the specification,A.sup.1 and A.sup.2 are a trans-1,4-cyclohexylene radical, 1,4-phenylene radical or other cyclic structure as further defined in the specification,Z.sup.1 and Z.sup.2 are a single bond or bridging group,L is H or F,m is 0, 1 or 2,Y is F or Cl, andQ is a single bond.
    Type: Grant
    Filed: September 18, 1995
    Date of Patent: June 24, 1997
    Assignee: Merck Patent Gesellschaft Mit Beschrankter Haftung
    Inventors: Volker Reiffenrath, Hans Adolf Kurmeier, Eike Poetsch, Herbert Plach, Ulrich Finkenzeller, Ekkehard Bartmann, Joachim Krause, Bernhard Scheuble
  • Patent number: 5536442
    Abstract: The invention relates to liquid crystal compounds having a terminal structure in accordance with formula 1, 2, 3 or 4:--A.sup.3 --OCF.sub.3 1--A.sup.2 --Q--CHF.sub.2 2--3,5-difluoro-1,4-phenylene-X.sup.1 3--3-fluoro-1,4-phenylene-X.sup.2 4wherein A.sup.2, A.sup.3, X.sup.1 and X.sup.2 and are defined herein. The invention further relates liquid crystal phases containing the above components as well as electrooptical displays containing same.
    Type: Grant
    Filed: July 6, 1992
    Date of Patent: July 16, 1996
    Assignee: Merck Patent Gesellschaft Mit Beschrankter Haftung
    Inventors: Volker Reiffenrath, Hans A. Kurmeier, Eike Poetsch, Herbert Plach, Ulrich Finkenzeller, Ekkehard Bartmann, Joachim Krause, Bernhard Scheuble, Dieter Dorsch, Georg Weber
  • Patent number: 5519525
    Abstract: The invention relates to a matrix liquid crystal display containing integrated non-linear elements and a liquid crystal mixture which has a particularly high resistivity.
    Type: Grant
    Filed: November 15, 1993
    Date of Patent: May 21, 1996
    Assignee: Merck Patent Gesellschaft Mit Beschrankter Haftung
    Inventors: Georg Weber, Ludwig Pohl, Reinhard Hittich, Herbert Plach, Bernhard Scheuble, Takamasa Oyama, Bernhard Rieger, Hans A. Kurmeier, Ekkehard Bartmann